Evidence map›Paper›PMID 35318496›Full record

ArticleBioprocess and biosystems engineering2022

Enhanced aerobic granular sludge formation by applying Phanerochaete chrysosporium pellets as induced nucleus.

Yihua Dong, Feng Chen, Liang Li, Zhiwen Yin, Xueying Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Bioprocess and biosystems engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yihua DongKey Laboratory of the Ministry of Education for Eco-Restoration of Regional Contaminated Environment, Shenyang University, Shenyang, 110044, Liaoning, China.
Feng ChenKey Laboratory of the Ministry of Education for Eco-Restoration of Regional Contaminated Environment, Shenyang University, Shenyang, 110044, Liaoning, China.
Liang LiSchool of Resources and Civil Engineering, Northeastern University, Shenyang, 110819, Liaoning, China. jxjj_1104@163.com.
Zhiwen YinKey Laboratory of the Ministry of Education for Eco-Restoration of Regional Contaminated Environment, Shenyang University, Shenyang, 110044, Liaoning, China.
Xueying ZhangKey Laboratory of the Ministry of Education for Eco-Restoration of Regional Contaminated Environment, Shenyang University, Shenyang, 110044, Liaoning, China.

Funding

China Major Science and Technology Program for Water Pollution Control and Treatment No. 2018ZX07601-002Liaoning Doctoral Research Start-up Fund No.2019-BS-087Shenyang Science and Technology Plan Fund Project No. 21-108-9-25
6 · The paper itself

Abstract

The long start-up period is a major challenging issue for the widespread application of aerobic granular sludge (AGS). In this study, a novel rapid start-up strategy was developed by inoculating Phanerochaete chrysosporium (P. chrysosporium) pellets as the induced nucleus in a sequencing batch airlift reactor (SBAR) to enhance activated sludge granulation. The results demonstrated that P. chrysosporium pellets could effectively shorten the aerobic granulation time from 32 to 20 days. The AGS promoted by P. chrysosporium pellets had a larger average diameter (2.60-2.74 mm) than that without P. chrysosporium pellets (1.78-1.88 mm) and had better biomass retention capacity and sedimentation properties; its mixed liquor suspended solids (MLSS) and sludge volume index (SVI

Indexed as

PhanerochaeteSewageAerobiosisBioreactorsNitrogenWaste Disposal, FluidNitrogenSewageAerobic granular sludgeBacterial communityExtracellular polymeric substancesPhanerochaete chrysosporium pelletsSequencing batch airlift reactor

Identifiers

PMID35318496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.